Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Ipol TM
Listen to the Pronunciation:
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: polio trivalent inactivated vaccine
Brand name
(ARTG)
: IPOL inactivated poliomyelitis vaccine 0.5mL injection syringeConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
Listen to the audio transcription of the CMI leaflet.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
Ipol is indicated for active immunisation of infants, children and adults for the prevention of poliomyelitis. Ipol should be offered to patients who have refused OPV or in whom OPV is contraindicated. Ipol is also indicated for: 1) the primary vaccination of immunocompromised individuals of all ages, and household contacts of such individuals (when vaccination is indicated); (2) unvaccinated or inadequately vaccinated(*) adults, particularly if at increased risk of exposure to live polio virus, including: - Travellers to areas or countries where poliomyelitis is epidemic or endemic: - Laboratory workers handling specimens which may contain polio virus; - Health care workers in close contact with patients who may be excreting polioviruses. (*) such as those who may not have completed a primary series of vaccination or not received a booster dose since infancy. IDICATIONS AS AT 9 JUNE 2003: Ipol is indicated for active immunisation of infants, children and adults for the prevention of poliomyelitis. Recommendations for the use of live and inactivated poliovirus vaccines are described in the NH&MRC's Immunisation Procedures book. 1) General Recommendations. It is recommended that all infants, immunised children and adolescents not previously immunised be vaccinated routinely against paralytic poliomyelitis. Ipol should be offered to patients who have refused OPV or in whom OPV is contraindicated. 2) Ipol is also indicated for: _ the primary vaccination of immunocompromised individuals of all ages (see PRECAUTIONS), and household contacts of such individuals (when vaccination is indicated); _ unvaccinated or inadequately vaccinated(*) adults, particularly if at increased risk of exposure to live poliovirus, including: - Travellers to areas or countries where poliomyelitis is epidemic or endemic; - Laboratory workers handling specimens which may contain poliovirus: - Health care workers in close contact with patients who may be excreting polioviruses. (*) such as those who had not completed a primary series of vaccination or not received a booster dose since infancy.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, suspension
- Subcutaneous
- Colourless clear solution .
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Do not Freeze
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 1 x 0.5mL pack
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Need more information?
These trusted information partners have more on this topic.
